Sangamo Therapeutics (SGMOQ) Share-based Compensation Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 0.26% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | -7.52% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -6.95% |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -32.65% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | -10.42% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -35.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -35.12% |
| Sep 30, 2025 | -35.84% |
| Jun 30, 2025 | -27.37% |
| Mar 31, 2025 | -4.52% |
| Dec 31, 2024 | -46.24% |
| Sep 30, 2024 | -46.44% |
| Jun 30, 2024 | -54.86% |
| Mar 31, 2024 | -67.15% |
| Dec 31, 2023 | -25.96% |
| Sep 30, 2023 | -20.58% |
| Jun 30, 2023 | -14.25% |
| Mar 31, 2023 | 7.62% |
| Dec 31, 2022 | 2.13% |
| Sep 30, 2022 | -1.02% |
| Jun 30, 2022 | -16.50% |
| Mar 31, 2022 | 2.22% |
| Dec 31, 2021 | 21.59% |
| Sep 30, 2021 | 17.82% |
| Jun 30, 2021 | 40.20% |
| Mar 31, 2021 | 33.88% |